SCHEMBL20052856

SCHEMBL20052856

CCCC1=NCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10955342 0.87 CHRM2 (0.36)
SCHEMBL6660516 0.87 HTR1D (0.40)
SCHEMBL2516256 0.84 ADRA2A (0.38)
SCHEMBL6292172 0.84 ADRA2A (0.38)
SCHEMBL2511670 0.84 ADRA2A (0.38)
SCHEMBL2512263 0.84 ADRA2A (0.38)
SCHEMBL10948416 0.84 ADRA2A (0.38)
SCHEMBL989255 0.82 ADRA2A (0.42)
SCHEMBL934243 0.81
Hydrochloric Acid SCHEMBL2417762 0.80 ADRA2A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109334132-B Anisotropic conductive film and method for producing same 迪睿合电子材料有限公司 2022-02-25 CN disclosed
US-20200216415-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-07-09 US disclosed
US-10604507-B2 Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-31 US disclosed
US-10562884-B2 Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-02-18 US disclosed
US-9944844-B2 Constraining pyrite activity in shale SMART CHEMICAL SERVICES, LP (US) 2018-04-17 US disclosed
CN-104710472-B Imidazolintrialkylphosphate compound, preparation method and ionic salt solution thereof, and preparation method of ionic salt solution 武汉海斯普林科技发展有限公司 2017-04-26 CN disclosed
US-8063036-B2 Benzamides and related inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-11-22 US disclosed